Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.11.1.7 (
peroxidase
)
65,474
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The localisation of lipopolysaccharide-binding sites on erythrocytes with
peroxidase
-coupled
LPS
is described.
LPS
was isolated from Fusobacterium nucleatum (Fus MC-8) by phenol-water extraction. The
LPS
was coupled to horseradish
peroxidase
by the two-step method of Avrameas and Ternynck (1971). The biological and serological activities of the conjugated
LPS
were compared with those of the native material. Peroxidase could be coupled to
LPS
without significant loss of endotoxic or serological activity. The
LPS
-
peroxidase
conjugate could be demonstrated on erythrocytes by light and electron microscopy.
...
PMID:Ultrastructural localisation of lipopolysaccharide-binding sites with peroxidase-conjugated lipopolysaccharides. 10 40
We made a sequential study of the proliferative and functional changes occurring in RE cells after beta 1-3 glucan administration in BDF1, and C57BL mouse. beta 1-3 glucan was administered by single i.v. 50 mg/kg or i.p. 15 mg/kg injection. This successively induced changes in RE cells as follows: on day 3 a rise of acid phosphatase activity in peritoneal macrophages; on day 6 an increase of 3H-TdR incorporation in spleen and peritoneal lymphocytes together with an intense suppression of PHA and
LPS
responses by spleen cells; on day 10 a 5-fold increase of the percentage of
peroxidase
rich monocytes in the peritoneum. Thereafter all the values went back to or below control. Our results indicate that beta 1-3 glucan is an in vivo mitogen and a macrophage activator.
...
PMID:Suppressor cell induction and reticuloendothelial cells activation produced in the mouse by beta 1-3 glucan. 16 47
A distinctive subpopulation of nonphagocytic, tightly adherent cells (NPAC) comprised approximately 6% of the adherent peritoneal cells from untreated mice, and about 18% of those from mice previously given BCG i.p. A separation procedure based on adherence and lack of phagocytosis was devised. Isolated NPAC were morphologically intermediate between small lymphocytes and macrophages. They were positive for nonspecific esterase, negative for
peroxidase
, positive for surface IgM, and negative for surface IgG1, IgG2 and IgA. When capped, their surface IgM regenerated in vitro. NPAC had demonstrable Fc receptors but not EAC receptors. They resisted killing by an anti-macrophage serum, were negative by immunofluorescence with an anti-T cell reagent, and incorporated increased amounts of thymidine in response to
LPS
but not to PHA. They were more readily killed with anti-Ia serum and complement than macrophages, but less readily than splenic B cells. NPAC appeared to represent a subpopulation of B lymphocytes which contaminates some preparations previously regarded as "macrophages" and which may be ressponsible for some of the activities previously ascribed to "macrophages".
...
PMID:Characterization of the nonphagocytic adherent cell from the peritoneal cavity of normal and BCG-treated mice. 32 54
Three different concentrations of horseradish
peroxidase
-labelled lipopolysaccharide (
LPS
-HRP) were added in vitro to spleen cells from the
LPS
high-responder strain C3H/Tif and to cells from the low-responder strain C3H/HeJ. After being washed and fixed the cells were exposed to the substrate and prepared for electron microscopy. After addition of 7 and 0.7 microgram/ml of labelled
LPS
only lymphocytes from the high-responder strain were labelled. About 5-10% of the cells from C3H/Tif bound
LPS
, which is in accordance with the known frequency of B cells possessing the genetically determined
LPS
receptor. At the highest dose of labelled
LPS
(70 microgram/ml) a large proportion of lymphocytes from the low-responder strain also bound
LPS
. Erythrocytes from both strains bound
LPS
at all concentrations. It is concluded that
LPS
-HRP allows the detection at the cellular level of
LPS
binding to the genetically controlled membrane receptor for
LPS
.
...
PMID:Bacterial lipopolysaccharides bind selectively to lymphocytes from lipopolysaccharide high-responder mouse strains. 39 66
Cells secreting immunoglobulins without detectable antibody function arising after an injection of horseradish
peroxidase
were micromanipulated from the center of haemolytic plaques of Sheep red blood cells coated with anti-Ig antibodies. These cells were cultured individually for 48 hrs, with irradiated cells as feeder layer and in the presence of the immunogen and of
LPS
. It was shown that after this time 22% of the immunoglobulin-secreting cells had generated antiperoxidase antibody-secreting cells or were transformed into antibody-secreting cells.
...
PMID:[Cells secreting antibodies originate from cells secreting immunoglobulins without a detectable antibody function for the antigen injected]. 41 38
Peritoneal macrophages from C3H/HeN mice treated i.p. with T cell mitogens or viable BCG organisms were cytotoxic to syngeneic tumor cells in vitro. Macrophages from endotoxin-unresponsive C3H/HeJ mice treated with BCG or T cell mitogens, however, were not tumoricidal. Furthermore, unlike cells from C3H/HeN mice, macrophages from C3H/HeJ mice could not be activated for tumor cytotoxicity after in vitro treatment with bacterial endotoxins or with lymphokine-rich supernatants. The subnormal induction of cytotoxic macrophages after in vitro or in vivo treatments in C3H/HeJ mice appears to be a highly selective defect. Macrophage responses (yield, phagocytosis, or
peroxidase
staining) in inflammatory exudates induced by BCG, T cell mitogens, or heterologous serum in C3H/HeJ or C3H/HeN mice were identical. C3H/HeJ macrophages also responded normally in vitor to chemotactic lymphokines. Thus, C3H/HeJ macrophages possess a profound and selective defect in tumoricidal capacity. This defect was not dependent upon exogenous endotoxins. Defective macrophage cytotoxic responses may reflect non-
LPS
related functions regulated by the
LPS
gene.
...
PMID:Defective tumoricidal capacity of macrophages from C3H/HeJ mice. 62 23
C receptor-1 is a protein involved in the regulation of C3 and C5-convertases. Recombinant human soluble C receptor-1 has recently been produced and shown to reduce infarct size in a rat model of myocardial ischemia/reperfusion injury. The present study aimed to investigate whether recombinant human soluble C receptor-1 exerts any protective effect on pulmonary injury produced in a rodent model of adult respiratory distress syndrome. In this model, Escherichia coli endotoxin (
LPS
, 0.1 microgram/kg) combined with platelet-activating factor (1 pmol/kg/min over 60 min, n = 10) caused microvascular lung injury characterized by elevation of
myeloperoxidase
activity, deposition of C3 and C5b-9 on the endothelium of pulmonary vessels, and pulmonary edema. Furthermore, bronchoalveolar lavage revealed increased neutrophil count and elevated protein concentration. These pulmonary responses were associated with elevated serum TNF-alpha. Pretreatment (10 min, i.v.) with recombinant human soluble C receptor-1 at 10 mg/kg (n = 13), but not at 1 mg/kg, prevented the
LPS
/platelet-activating factor-induced pulmonary edema (p less than 0.01) and changes in the bronchoalveolar lavage fluid cell count (p less than 0.01) and protein concentration (p less than 0.05), and attenuated the deposition of C3 and C5b-9 to lung vessels. There was no effect on lung
myeloperoxidase
activity and serum TNF-alpha. Also, C depletion by cobra venom factor (500 U/kg, i.v.) eliminated the pulmonary edema and elevated leukocyte count in bronchoalveolar lavage fluid, but had no effect on lung
myeloperoxidase
activity and serum TNF-alpha. These data suggest that C factors may play an important role in the pathophysiology of adult respiratory distress syndrome.
...
PMID:Role of complement in endotoxin/platelet-activating factor-induced lung injury. 132 80
We have recently reported that 45 min of gut ischemia causes moderate 125I-albumin lung leak at 6 hr of reperfusion which was reversed at 18 hr. Our purpose was to determine the effect of a second insult, low dose endotoxin (
LPS
, 2.5 mg/kg), given 6 hr after gut ischemia/reperfusion (I/R) on this lung injury as assessed by 125I-albumin leak, neutrophil influx (
myeloperoxidase
assay,
MPO
), histopathology, and mortality. Rats were randomized to either sham laparotomy (LAP) or 45 min of superior mesenteric artery occlusion and 6 hr later were treated with
LPS
or saline. At 18 hr reperfusion the lungs were harvested, assayed for 125I-albumin leak and
MPO
, and microscopically examined by an unbiased observer after routine H&E staining. We observed that
LPS
increased lung neutrophil levels both with or without gut I/R. However, only the combined insult (I/R +
LPS
) increased 125I-albumin leak at 18 hr of reperfusion. Lung histology confirmed that the sequential combination of I/R +
LPS
caused marked interstitial edema and neutrophil sequestration accompanied by alveolar edema, hemorrhage, and fibrinous exudate, while I/R or LAP +
LPS
did not. The mortality rate of I/R +
LPS
was 39% which was significantly higher than LAP alone (0%), gut I/R alone (0%), or LAP +
LPS
(4%). In conclusion, a delayed exposure to low dose endotoxin converts moderate gut I/R-induced lung dysfunction into advanced organ failure.
...
PMID:Endotoxin after gut ischemia/reperfusion causes irreversible lung injury. 132 81
Both gram-negative infection and bacterial endotoxin (lipopolysaccharide,
LPS
) produce a marked neutropenia and increase glucose disposal by peripheral tissues. The purpose of the present study was to determine whether leukocyte depletion before these insults would diminish the commonly observed increases in tissue glucose uptake. Rats were depleted of circulating and marginated leukocytes with cyclophosphamide (CPA). Under basal postabsorptive conditions the subcutaneous injection of live Escherichia coli into control animals enhanced whole body glucose disposal that resulted in part from a stimulation of glucose uptake by the liver, spleen, intestine, and lung. These increases in tissue glucose uptake were not associated with an increase in neutrophil number, as assessed by
myeloperoxidase
(
MPO
) activity. CPA-induced leukopenia did not alter the sepsis-induced increase in glucose uptake by these tissues and whole body glucose use remained elevated. In contrast, skin and muscle proximal to the site of infection showed an increase in both glucose uptake and
MPO
activity. Furthermore, leukocyte depletion attenuated the elevated glucose uptake by skin and muscle near the inflammatory focus. The intravenous injection of
LPS
also increased whole body glucose disposal and enhanced glucose uptake by the lung, liver, spleen, intestine, and skin in saline-treated rats. Of these tissues the lung, liver, and spleen had a corresponding increase in neutrophil number. The
LPS
-induced increases in tissue glucose uptake in leukopenic rats were comparable, with the exception of liver and lung. In these tissues the incremental increase in glucose uptake after
LPS
was reduced 40-50% in leukopenic animals.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:Sepsis- and endotoxin-induced increase in organ glucose uptake in leukocyte-depleted rats. 133 18
After administration of bacterial lipopolysaccharide, there is an increase in the number of leucocytes which adhere to the endothelial cell surface of the hepatic vessels and pass through the endothelial layer by comparison with controls. There is also marked endothelial cell damage including intracytoplasmic oedema, increased numbers of autophagic vacuoles and dilatation of the intercellular junction in
LPS
-treated samples. The presence of immunocytochemical products of leukotriene (LTR) and tumour necrosis factor (TNF) was examined using in both
LPS
-treated and control samples. Immunoreactions of LTR which were seen in specific granules of neutrophils and monocytes attached to the endothelial cell surface may indicate the onset of endothelial cell damage. Positive immunoreactions of TNF on the endothelial cell surface, seen only in
LPS
-treated samples, indicate that TNF may enhance the passage of blood cells through the endothelia and also increase the endocytotic activity of the liver parenchymal cells, as revealed by the present marker experiment using horseradish
peroxidase
. Positive reactions of TNF in lysosomes of the endothelial cells suggest that they are able to produce TNF and transport it to the cell surface.
...
PMID:The immunocytochemical localization of tumour necrosis factor and leukotriene in the rat liver after treatment with lipopolysaccharide. 141 81
1
2
3
4
5
6
7
8
9
10
Next >>